Related Experiment Video
Updated: Jun 4, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Relation between dysbiosis and inborn errors of immunity
1Department of Pediatric Allergy and Immunology, Sakarya University, Medical Faculty, Adapazarı 54100, Sakarya, Türkiye. ozdemir_oner@hotmail.com.
Inborn errors of immunity (IEI) are linked to microbial imbalances, known as dysbiosis. Restoring gut microbiota balance through therapies like probiotics may improve IEI disease severity and outcomes.
Area of Science:
- Immunology
- Microbiology
- Genetics
Background:
- Inborn errors of immunity (IEI) encompass diverse genetic disorders affecting immune system function.
- Clinical manifestations in IEI are often exacerbated by inflammatory and immune dysregulation linked to microbial dysbiosis.
- Specific IEI, like common variable immunodeficiency and hyper-IgE syndrome, show altered gut and oral microbiota.
Purpose of the Study:
- To explore the relationship between IEI and microbial dysbiosis.
- To investigate the potential of microbiota modulation as a therapeutic strategy for IEI patients.
Main Methods:
- Review of existing literature on IEI and associated microbial alterations.
- Analysis of studies examining gut and oral microbiota in IEI patients.
- Identification of therapeutic interventions targeting microbiota modification.
Main Results:
- Reduced microbial diversity in the gut microbiota of common variable immunodeficiency patients correlates with disease severity.
- STAT3/Th17 pathway compromise in hyper-IgE syndrome can lead to oral dysbiosis and pathogenic *Candida albicans*.
- Microbiota modification strategies show promise in restoring balance and reducing pathogenicity.
Conclusions:
- Dysbiosis is a significant factor contributing to the phenotype and complications of IEI.
- Therapeutic interventions such as prebiotics, probiotics, postbiotics, and fecal microbiota transplantation offer potential treatment avenues for IEI.
- Ongoing clinical trials aim to further elucidate the impact of dysbiosis on IEI and its therapeutic implications.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Humoral Immune Responses
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

